BIOMAT Database Logo BIOMAT Database Logo

[Studies on thyroid hormone autoantibody (THAA) in 2 cases of Graves' disease with spuriously high free thyroxine values]. 1991

N Fukasawa, and M Iitaka, and Y Hara, and M Yanagisawa, and K Hase, and S Miura, and Y Sakatume, and J Ishii
Fourth Department of Internal Medicine, Saitama Medical School, Japan.

Two patients with Graves' disease treated with methimazole (MMI) showed a discrepancy between serum free T4 (FT4) values and other hormone values (especially total T4) which was due to the presence of potent binding activity to labelled T4 analogue (125I-aT4) in their serum. This activity was demonstrated to be in immunoglobulin G (IgG) with kappa light chain isotype in both patients. The binding of 125I-aT4 to their serum was inhibited by unlabelled T4 in a dose-dependent manner. Autoantibodies had almost identical binding affinity to T4 and aT4, although they precipitated more radioactivity when 125I-aT4 was used. The binding of IgG purified from patients' sera to labelled T4 or aT4 was not greater than the corresponding sera, suggesting that the thyroxine binding proteins did not interfere with the assay. Since the specific radioactivity of 125I-aT4 is almost 10 times higher than that of 125I-T4, autoantibodies can precipitate almost 10 times more radioactivity in the FT4 assay than the total T4 assay, thus leading to the spuriously high FT4 values and large discrepancy between FT4 and TT4 values.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008713 Methimazole A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme. Methymazol,Thiamazole,1-Methyl-2-mercaptoimidazole,Favistan,Mercasolyl,Mercazol,Mercazole,Mercazolyl,Merkazolil,Methizol,Methylmercaptoimidazole,Metisol,Metizol,Strumazol,Tapazole,Thiamazol Henning,Thiamazol Hexal,Thimazol,Thyrozol,Tiamazol,Tirodril,1 Methyl 2 mercaptoimidazole,Henning, Thiamazol,Hexal, Thiamazol
D005260 Female Females
D006111 Graves Disease A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). Basedow's Disease,Exophthalmic Goiter,Goiter, Exophthalmic,Graves' Disease,Basedow Disease,Hyperthyroidism, Autoimmune,Basedows Disease,Disease, Basedow,Disease, Basedow's,Disease, Graves,Disease, Graves',Exophthalmic Goiters,Goiters, Exophthalmic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D013974 Thyroxine The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. L-Thyroxine,Levothyroxine,T4 Thyroid Hormone,3,5,3',5'-Tetraiodothyronine,Berlthyrox,Dexnon,Eferox,Eltroxin,Eltroxine,Euthyrox,Eutirox,L-3,5,3',5'-Tetraiodothyronine,L-Thyrox,L-Thyroxin Henning,L-Thyroxin beta,L-Thyroxine Roche,Levo-T,Levothroid,Levothyroid,Levothyroxin Deladande,Levothyroxin Delalande,Levothyroxine Sodium,Levoxine,Levoxyl,Lévothyrox,Novothyral,Novothyrox,O-(4-Hydroxy-3,5-diiodophenyl) 3,5-diiodo-L-tyrosine,O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine,Oroxine,Sodium Levothyroxine,Synthroid,Synthrox,Thevier,Thyrax,Thyroxin,Tiroidine,Tiroxina Leo,Unithroid,L Thyrox,L Thyroxin Henning,L Thyroxin beta,L Thyroxine,L Thyroxine Roche,Levo T,Thyroid Hormone, T4

Related Publications

N Fukasawa, and M Iitaka, and Y Hara, and M Yanagisawa, and K Hase, and S Miura, and Y Sakatume, and J Ishii
[Studies on thyroid hormone autoantibody in two euthyroid cases with spuriously high value of serum free triiodothyronine].
November 1992, Nihon Naibunpi Gakkai zasshi,
N Fukasawa, and M Iitaka, and Y Hara, and M Yanagisawa, and K Hase, and S Miura, and Y Sakatume, and J Ishii
Spuriously high free thyroxine values in familial dysalbuminemic hyperthyroxinemia.
March 2011, Clinical chemistry,
N Fukasawa, and M Iitaka, and Y Hara, and M Yanagisawa, and K Hase, and S Miura, and Y Sakatume, and J Ishii
Thyroid hormone autoantibodies (THAA) in two cases of Graves' disease: effects of antithyroid drugs, prednisolone, and subtotal thyroidectomy.
December 1986, Endocrinologia japonica,
N Fukasawa, and M Iitaka, and Y Hara, and M Yanagisawa, and K Hase, and S Miura, and Y Sakatume, and J Ishii
Spuriously high free thyroxine with the Access free T4 assay.
March 1998, Clinical biochemistry,
N Fukasawa, and M Iitaka, and Y Hara, and M Yanagisawa, and K Hase, and S Miura, and Y Sakatume, and J Ishii
Spuriously high free thyroxine with the Amerlite MAB FT4 assay.
February 1994, Journal of clinical pathology,
N Fukasawa, and M Iitaka, and Y Hara, and M Yanagisawa, and K Hase, and S Miura, and Y Sakatume, and J Ishii
Composite reference interval for thyroid-stimulating hormone and free thyroxine, comparison with common cutoff values, and reconsideration of subclinical thyroid disease.
November 2009, Clinical chemistry,
N Fukasawa, and M Iitaka, and Y Hara, and M Yanagisawa, and K Hase, and S Miura, and Y Sakatume, and J Ishii
Spuriously high concentration of serum free thyroxine due to anti-triiodothyronine antibodies.
January 1995, Clinical chemistry,
N Fukasawa, and M Iitaka, and Y Hara, and M Yanagisawa, and K Hase, and S Miura, and Y Sakatume, and J Ishii
Postmortem values of thyroxine and thyroid stimulating hormone.
January 1973, Journal of forensic sciences,
N Fukasawa, and M Iitaka, and Y Hara, and M Yanagisawa, and K Hase, and S Miura, and Y Sakatume, and J Ishii
[Serum free thyroxine in thyroid diseases, with special reference to Graves' disease during the treatment].
November 1983, Horumon to rinsho. Clinical endocrinology,
N Fukasawa, and M Iitaka, and Y Hara, and M Yanagisawa, and K Hase, and S Miura, and Y Sakatume, and J Ishii
[Two cases of untreated Graves' disease associated with anti-thyroid hormone antibodies].
May 1989, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Copied contents to your clipboard!